Specific features of erythrocyte membranes and metabolism in patients with lung cancer
Stepovaia, E.A.; Novitskiĭ, V.V.; Goldberg, V.E.; Riazantseva, N.V.; Tkachenko, S.B.; Kolosova, M.V.
Voprosy Onkologii 50(1): 63-67
2004
ISSN/ISBN: 0507-3758 PMID: 15088524 Document Number: 568010
A study of erythrocyte metabolism and membrane status has identified the structurally and metabolically deranged mature erythrocytes, both in anemic and anemia-free patients with stage III-IV lung cancer. Anemia incidence in non-small-cell lung cancer was significantly higher than in the small-cell lung cancer group.
Document emailed within 1 workday
Related Documents
Kokarev, A.N.; Kardakov, I.I.; Kas'ianov, L.S.; Pesotskiĭ, A.S. 1991: Pathogenetic role of disorders of cholesterol metabolism in erythrocyte membranes in patients with exertion-induced angina pectoris Kardiologiia 31(2): 45-47Makshanova, G.P.; Ust'iantseva, I.M.; Petukhova, O.V.; Agadzhanian, V.V. 2003: Erythrocyte membranes permeability and lipid metabolism in patients with multiple traumas depending on early and delayed surgical treatment Fiziologiia Cheloveka 29(1): 95-99
Stepovaia, E.A.; Novitskiĭ, V.V.; Riazantseva, N.V.; Tkachenko, S.B.; Gol'dberg, V.E.; Kolosova, M.V. 2004: Protein composition of erythrocyte membranes in patients with stomach, colon and rectal cancer Klinicheskaia Laboratornaia Diagnostika 5: 50-53
Goncharov, N.P.; Vorontsov, V.I.; Goncharova, N.D.; Bazilevskaia, L.G.; Lomaia, L.P. 1977: Specific features of steroid hormone metabolism in patients with chronic lympholeukemia Problemy Gematologii i Perelivaniia Krovi 22(6): 36-40
Nisenbaum, G.D.; Liakhnovich, G.V.; Konev, S.V. 1978: Structural transformation of human erythrocyte membranes initiated by group specific antibodies Biofizika 23(4): 641-644
Shoji, M.; Kawamoto, S.; Sato, S.; Kamei, M.; Kato, M.; Hashizume, S.; Seki, K.; Yasumoto, K.; Nagashima, A.; Nakahashi, H. 1994: Specific reactivity of human monoclonal antibody AE6F4 against cancer cells in tissues and sputa from lung cancer patients Human Antibodies and Hybridomas 5(3-4): 116-122
Abood, L.G.; Grassi, S.; Junig, J.; Crane, A.; Costanzo, M. 1985: Specific binding and metabolism of (-)- and (+)-[3H]-nicotine in isolated rat hepatocytes and hepatocyte membranes Archives Internationales de Pharmacodynamie et de Therapie 273(1): 62-73
Bogush, T.A.; Tseĭtlin, G.I.; Bukhny, A.F. 1992: The rate of antipyrine metabolism in cancer patients administered specific therapy Voprosy Onkologii 38(11): 1288-1293
Richards, E.W.; Long, C.L.; Nelson, K.M.; Pinkston, J.A.; Navari, R.M.; Geiger, J.W.; Gandy, R.E.; Blakemore, W.S. 1992: Glucose metabolism in advanced lung cancer patients Nutrition 8(4): 245-251
Gmiński, J.; Mykala-Cieśla, J.; Machalski, M.; Drózdz, M. 1993: Elastin metabolism parameters in sera of patients with lung cancer Neoplasma 40(1): 41-44
Todoriko, L.D. 1998: Changes in the morphofunctional state of the erythrocyte membranes in bronchial asthma in patients of different ages Likars'ka Sprava 1998(2): 51-54
Yasuda, S.; Shimada, K.; Matsumura, K.; Horie, S. 1985: The metabolism of trace metals in patients with lung cancer--with special reference to zinc Nihon Kyobu Shikkan Gakkai Zasshi 23(3): 363-367
Liu, Y.-q.; Guo, R.-h.; Liu, L.-k.; Gao, W.; Zhu, C.-j.; Wei, J.; Shu, Y.-q. 2011: Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC) Zhonghua Zhong Liu Za Zhi 33(6): 426-430
Kawano, R.; Hata, E.; Ikeda, S.; Yokota, T. 2008: Lobe-specific skip nodal metastasis in non-small cell lung cancer patients Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 14(1): 9-14
Minkov, I.P. 1991: Erythrocyte membranes in patients with congenital cyanotic heart disease before and after obsidan therapy Kardiologiia 31(10): 66-68
Postnov, I.I.; Liusov, V.A. 1985: Sodium permeability of erythrocyte membranes of essential hypertension patients with and without a hereditary predisposition to the disease Kardiologiia 25(1): 47-50
Li, Z.; Zhang, L-jun.; Wang, W-ping.; Guo, K.; Shao, J-yong.; Rong, T-hua. 2011: Correlation between EGFR gene mutation and high copy number and their association with the clinicopathological features in Chinese patients with non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 33(9): 666-670
Fukuoka, M.; Takada, M.; Kamei, T.; Negoro, S.; Kusunoki, Y.; Matsui, K.; Ryu, S.; Sakai, N.; Takifuji, N.; Masuda, N. 1987: Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 2): 871-880
Body, J.J.; Paesmans, M.; Sculier, J.P.; Dabouis, G.; Bureau, G.; Libert, P.; Berchier, M.C.; Raymakers, N.; Klastersky, J. 1992: Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer Clinical Chemistry 38(5): 748-751
Schneider, J.; Philipp, M.; Salewski, L.; Hans-Georg Velcovsky 2003: Pro-Gastrin-Releasing Peptide (ProGRP) and Neuron Specific Enolase (NSE) inTherapy Control of Patients with Small-Cell Lung Cancer Clinical Laboratory 49(1-2): 35-42